CGON
CG Oncology, Inc.
72.61
-0.03 (-0.04%)
52w low 37.01
80.97 high
81.0% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 14.62M | 45.15M | 32.49M | 33.70M | 19.64M | |
| Receivables | -- | -- | 515.00K | 688.00K | 1.27M | 417.00K | |
| Inventory | -- | -- | 1.50M | 1.56M | 1.49M | 1.00M | |
| Current Assets | -- | 673.03M | 695.79M | 759.48M | 1.10B | 1.05B | |
| Net PP&E | -- | 1.22M | 19.53M | 19.57M | 19.59M | 20.44M | |
| Total Assets | -- | 701.45M | 729.91M | 791.59M | 1.14B | 1.09B | |
| Current Liabilities | -- | 30.38M | 30.53M | 30.84M | 35.22M | 47.24M | |
| Total Debt | -- | 994.00K | 7.24M | 7.02M | 7.58M | 8.82M | |
| Total Liabilities | -- | 31.09M | 42.27M | 38.99M | 43.48M | 56.54M | |
| Retained Earnings | -- | -293.86M | -337.67M | -378.98M | -439.18M | -518.23M | |
| Shareholders Equity | -- | 670.36M | 687.64M | 752.60M | 1.09B | 1.03B | |
| Working Capital | -- | 642.65M | 665.26M | 728.64M | 1.07B | 1.00B | |
| Shares Outstanding | -- | 76.23M | 78.28M | 80.69M | 88.01M | 88.31M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+6.8%